精神医学杂志
精神醫學雜誌
정신의학잡지
JOURNAL OF PSYCHIATRY
2015年
3期
192-194
,共3页
陈龙涛%曹九英%许律琴%谭常赞%朱建忠%范鲁%娄元菊%宋西俊%黄秋明
陳龍濤%曹九英%許律琴%譚常讚%硃建忠%範魯%婁元菊%宋西俊%黃鞦明
진룡도%조구영%허률금%담상찬%주건충%범로%루원국%송서준%황추명
女性%精神分裂症%哌罗匹隆%氨磺必利
女性%精神分裂癥%哌囉匹隆%氨磺必利
녀성%정신분렬증%고라필륭%안광필리
Female%Schizophrenia%Perospirone%Amisulpride
目的:探讨哌罗匹隆与氨磺必利对首发女性精神分裂症患者的临床疗效及安全性。方法将100例首发女性精神分裂症患者随机分为哌罗匹隆组和氨磺必利组各50例,分别给予哌罗匹隆和氨磺必利治疗,分别于治疗前和治疗后第8周末应用阳性和阴性综合征量表( PANSS)及治疗中需处理的不良反应症状量表( TESS)进行评分,在治疗12个月末采用生存质量测定量表( QOL-100)量表评定患者的生活质量。结果治疗后第8周末,两组总有效率比较差异无统计学意义(P>0.05),哌罗匹隆组总不良反应发生率(22.00%)低于氨磺必利组(48.00%)(P<0.05)。治疗12个月末,哌罗匹隆组QOL-100量表总分高于氨磺必利组(P<0.05)。结论哌罗匹隆与氨磺必利对首发女性精神分裂症患者均有较好疗效,但哌罗匹隆的不良反应发生率更低,患者治疗后生活质量更高。
目的:探討哌囉匹隆與氨磺必利對首髮女性精神分裂癥患者的臨床療效及安全性。方法將100例首髮女性精神分裂癥患者隨機分為哌囉匹隆組和氨磺必利組各50例,分彆給予哌囉匹隆和氨磺必利治療,分彆于治療前和治療後第8週末應用暘性和陰性綜閤徵量錶( PANSS)及治療中需處理的不良反應癥狀量錶( TESS)進行評分,在治療12箇月末採用生存質量測定量錶( QOL-100)量錶評定患者的生活質量。結果治療後第8週末,兩組總有效率比較差異無統計學意義(P>0.05),哌囉匹隆組總不良反應髮生率(22.00%)低于氨磺必利組(48.00%)(P<0.05)。治療12箇月末,哌囉匹隆組QOL-100量錶總分高于氨磺必利組(P<0.05)。結論哌囉匹隆與氨磺必利對首髮女性精神分裂癥患者均有較好療效,但哌囉匹隆的不良反應髮生率更低,患者治療後生活質量更高。
목적:탐토고라필륭여안광필리대수발녀성정신분렬증환자적림상료효급안전성。방법장100례수발녀성정신분렬증환자수궤분위고라필륭조화안광필리조각50례,분별급여고라필륭화안광필리치료,분별우치료전화치료후제8주말응용양성화음성종합정량표( PANSS)급치료중수처리적불량반응증상량표( TESS)진행평분,재치료12개월말채용생존질량측정량표( QOL-100)량표평정환자적생활질량。결과치료후제8주말,량조총유효솔비교차이무통계학의의(P>0.05),고라필륭조총불량반응발생솔(22.00%)저우안광필리조(48.00%)(P<0.05)。치료12개월말,고라필륭조QOL-100량표총분고우안광필리조(P<0.05)。결론고라필륭여안광필리대수발녀성정신분렬증환자균유교호료효,단고라필륭적불량반응발생솔경저,환자치료후생활질량경고。
Objective To explore the efficacy of perospirone and amisulpride in treatment of female patients with schizophrenia in first-episode.Methods A total of 100 female patients with schizophrenia in first -episode were randomly divided into perospirone group with perospirone and amisulpride group with amisulpride for treatment of 8 weeks.They were assessed with positive and negative symptom scale ( PANSS) and side effects scale ( TESS) before treatment and in the 8th weekend of treatment, quality of life scale (QOL-100)in the 12th month end after treatment.Results In the 8th weekend of treatment, there was no difference in the total effective rate between perospirone group(88%) and amisulpride group(86%) ( P>0.05), but the rate of side effects in perospirone group were significantly less than those in amisulpride group(P<0.05).In the 12th month end after treatment, the total scores of QOL-100 in perospirone group were significantly more than those in amisulpride group(P <0.05).Conclusion It’ s effective for perospirone and amisulpride to treat the female patients with schizophrenia in first-episode, but perospirone is more safe and helpful to improve the quality of life in the patients.